Keyword

vicriviroc

Description: Vicriviroc is an investigational antiviral drug that blocks the CCR5 receptor, which HIV-1 can use to enter host cells.
Wikidata ID: wiki/Q3557001
OpenAlex ID: keywords/vicriviroc
2012 · Marco Velasco-Velázquez, Xuanmao Jiao, et al. · Cancer Research · 315
2019 · Xuanmao Jiao, Omar Nawab, et al. · Cancer Research · 251
2005 · Julie M. Strizki, Cecile Tremblay, et al. · Antimicrobial Agents and Chemotherapy · 231
2010 · A. D. Furlan, R. Reardon, et al. · Canadian Medical Association Journal · 204
2007 · Rama Kondru, Jun Zhang, et al. · Molecular Pharmacology · 204
2009 · Daniel R Kuritzkes · Current Opinion in HIV and AIDS · 180
2005 · Mike Westby, Elna van der Ryst · Antiviral chemistry & chemotherapy · 149
2018 · Xuanmao Jiao, Marco A. Velasco-Velázquez, et al. · Cancer Research · 139
2010 · Dirk Eggink, Ben Berkhout, et al. · Current Pharmaceutical Design · 116
2008 · Athe M. N. Tsibris, Manish Sagar, et al. · Journal of Virology · 114
2009 · John P Moore, Daniel R Kuritzkes · Current Opinion in HIV and AIDS · 103
2009 · Cleo G. Anastassopoulou, Thomas J. Ketas, et al. · Proceedings of the National Academy of Sciences · 99
2006 · Jose D. Murga, Michael Franti, et al. · Antimicrobial Agents and Chemotherapy · 98
2009 · Kevin C. Brown, Sunita Paul, et al. · Clinical Pharmacokinetics · 93
2009 · Laura Dickinson, Saye Khoo, et al. · Antiviral Research · 89
2010 · Marco Donia, James A. McCubrey, et al. · British Journal of Clinical Pharmacology · 84
Works count: 164
Citation count: 5,862
Year
Topic
Type